Dr. William Harmon Tettelbach, MD

Dr. Tettelbach practices at Brigham City Community Hospital in Brigham City, Utah, part of HCA Healthcare.

Dr. Tettelbach's NPI, 1336143361, was assigned on June 8, 2005. Dr. Tettelbach graduated from University of Tennessee, Hsc, College of Medicine in 1995. Dr. Tettelbach holds Utah license 351005-1205.

Dr. Tettelbach's primary practice is Brigham City Community Hospital, at 950 South Medical Drive, Brigham City, UT 84302 in Box Elder County. The practice phone is (435) 734-9471.

Dr. Tettelbach's primary practice is Brigham City Community Hospital in Brigham City, Utah, part of HCA Healthcare. The medical group on file is Silverton Group. Dmand AI also links Dr. Tettelbach to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tettelbach practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Tettelbach's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Tettelbach's licenses on file in 2 states: Utah and Tennessee.

CMS data shows 213 Medicare services from Dr. Tettelbach across 4 procedure codes in 2023, for 13 Medicare patients. Medicare paid $8,337 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Dr. Tettelbach in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure. Their average risk score is 4.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tettelbach's median patient age at 66, with 44% women.

In 2023, Dr. Tettelbach wrote 53 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $3,081 in total drug cost. In 2017, CMS named 128 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tettelbach for performance year 2024, reported as part of a group. Dr. Tettelbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of removal of tissue by Dr. Tettelbach, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Tettelbach, published from 2014 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Wound Healing, Allografts and Diabetic Foot. Dr. Tettelbach has published most often in J Wound Care. Dr. Tettelbach's most frequent co-authors are Naz A. Wahab, MD, Mark D. Suski, MD and Michael N. Desvigne, MD.

Dmand AI links Dr. Tettelbach to 1 clinical trial. Conditions studied include Diabetic Foot and Foot Ulcer.

CMS Open Payments shows 167 general payments to Dr. Tettelbach from 23 drug and device companies from 2016 to 2025. Debt forgiveness make up the largest share, 79% of the total. ConvaTec Inc. paid the most, $550,414.

Dr. Tettelbach graduated from University of Tennessee, Hsc, College of Medicine in 1995.